COVID-19-Associated Maxillary Osteomyelitis: A Case Report
Journal of Dental School,
Vol. 41 No. 4 (2023),
7 May 2024
,
Page 162-163
https://doi.org/10.22037/jds.v41i4.44509
Abstract
Objectives Mucormycosis, a lethal opportunistic infection, is associated with high rates of morbidity and mortality. The pathogenesis of this disease appears to be multifactorial, with numerous factors contributing to its onset and progression, particularly in relation to COVID-19 infection.
Case The presented case was a 41-year-old male who had a history of COVID-19 infection and had received high-dose corticosteroid therapy. He presented with a painless, extensive necrotic lesion on the right maxilla.
Conclusion A biopsy confirmed the diagnosis of maxillary mucormycotic osteomyelitis associated with COVID-19. Overall, understanding this severe infection is crucial for accurate diagnosis and prompt treatment.
- Osteomyelitis
- COVID-19
- Maxilla
- Mucormycosis
How to Cite
References
- Anehosur V, Agrawal SM, Joshi VK, Anand J, Krishnamuthy K, Kumar N. Incidence and Treatment Protocol for Maxillofacial Fungal Osteomyelitis: A 12-Year Study. J Oral Maxillofac Surg. 2019; 77(11):2285-91.
- Mendhe D, Wankhede P, Wanjari M, Alwadkar S. Mucormycotic osteomyelitis of maxilla post-COVID patient: a case report. Pan Afr Med J. 2021;39:275.
- Suresh A, Joshi A, Desai AK, Juturu U, Kurian DJ, Jain P, et al. Covid-19 Associated Fungal Osteomyelitis of Jaws and Sinuses: An experience driven management protocol. Med Mycol. 2022; 60(2):myab082.
- Srivastava A, Mohpatra M, Mahapatra A. Maxillary Fungal Osteomyelitis: A Review of Literature and Report of a Rare Case. Ann Maxillofac Surg. 2019;9(1):168-173.
- Ambereen A, Rahman SA, Rehman S, Zaidi K, Arif SH. Mandibular mucormycosis following SARS-CoV-2 infection - A case report and review of literature. Clin Infect Pract. 2021;12:100099.
- Abstract Viewed: 153 times
- PDF Downloaded: 62 times